Opioid Risk Tool (ORT)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low0–3
- Moderate4–7
- High≥ 8
The Opioid Risk Tool (ORT) calculates screening symptom severity, assessing suicide risk, and monitoring psychotherapeutic response. Key inputs include sex. Scores guide establishing safety containment plans, initiating pharmacotherapy, and scheduling close outpatient psychiatric review. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Opioid Risk Tool (Webster 2005) for aberrant opioid behavior risk: gender-weighted items — family substance abuse (F3/M3), personal substance abuse (F4/M4), age 16-45 (1), preadolescent sexual abuse (F3/M0), psychological disease (F2/M2). Total: 0-3 low, 4-7 moderate, ≥8 high.
Clinical Indication
The Opioid Risk Tool (ORT) is indicated for bedside clinical practice to support Opioid Risk Tool (Webster 2005) for aberrant opioid behavior risk: gender-weighted items — family substance abuse (F3/M3), personal substance abuse (F4/M4), age 16-45 (1), preadolescent sexual abuse (F3/M0), psychological disease (F2/M2). Total: 0-3 low, 4-7 moderate, ≥8 high.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients undergoing evaluation for mood disorders, anxiety, psychosis, cognitive impairment, or suicidal ideation. Clinical application is indicated across Psychiatric emergency services, inpatient behavioral health units, and outpatient psychiatric clinics.
Limitations & Contraindications
Patient self-report bias, cognitive impairment, or acute intoxication can significantly skew questionnaire scoring.
Clinical Pearls & Action Plan
Standardized clinical rating scales serve as diagnostic adjuncts and cannot substitute for an exhaustive clinical psychiatric interview.
ORT = sum of gender-weighted items.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Patient's sex (weights differ) |
| family_hx | string | Yes | Family history of substance abuse |
| personal_hx | string | Yes | Personal history of substance abuse |
| age_16_45 | string | Yes | Age 16-45 |
| abuse_hx | string | Yes | History of preadolescent sexual abuse |
| psych_hx | string | Yes | Psychological disease (ADHD, OCD, bipolar, schizophrenia, depression) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | Low | Low risk |
| 4–7 | Moderate | Moderate risk |
| ≥ 8 | High | High risk |
Evidence-Based References (EBM)
- Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442.